Warburg leads $255m Series C in HK-based AI drug discovery firm Insilico Medicine

Insilico Medicine, a Hong Kong-based firm that uses artificial intelligence (AI) for drug discovery and ageing research, announced on Tuesday that it has raked in $255 million in a Series C round of financing led by US private equity (PE) giant Warburg Pincus.